Health & Biotech
Antisense Therapeutics (ASX: ANP) has changed its name to Percheron Therapeutics - PER (ASX: PER).
Below are the previous articles from Antisense Therapeutics (ASX: ANP):
RELATED STOCKHEAD STORIES
Health & Biotech
Biotech exec pay — are they delivering returns that equal their pay packets?
Health & Biotech
Dr Boreham’s Crucible: Can Phylogica finally make magic happen after nearly 15 years of trying?
News
Trading Places: Here are this week’s substantial holder movements
Health & Biotech
Health: FDA approval is eye candy for Visioneering’s kiddie contact lens
Health & Biotech
These are the 22 small cap biotechs closest to bringing a drug to market
Health & Biotech
The life sciences investment wave is building. Here’s how to ride it.
News
Lunchtime ASX small cap wrap: Who’s blaming the umpiring today?
Stockhead TV
Video: 90 Seconds With… Mark Diamond, Antisense Therapeutics
Health & Biotech
Check-up: Medicinal cannabis investment puts an energy company in top spot
News
Lunchtime ASX small cap wrap: Who’s pointing the finger today?
Health & Biotech
Health: Cynata has finally scored that Fujifilm deal; shares climb 27pc
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: Antisense wants to conquer the less crowded DMD market
News
Lunchtime ASX small cap wrap: Who’s planning for the future?
Health & Biotech
Biotech entrepreneur Paul Hopper tells us why he joined ‘treasure chest’ Suda
Health & Biotech
Antisense Therapeutics looks to give boys a lifeline; launches DMD Phase 2 trial
Health & Biotech